UK markets close in 1 hour 19 minutes

  • FTSE 100

    7,007.90
    +24.40 (+0.35%)
     

  • FTSE 250

    22,502.78
    +30.74 (+0.14%)
     

  • AIM

    1,250.45
    +2.32 (+0.19%)
     

  • GBP/EUR

    1.1518
    +0.0007 (+0.06%)
     

  • GBP/USD

    1.3806
    +0.0021 (+0.15%)
     

  • BTC-GBP

    44,224.59
    -1,522.87 (-3.33%)
     

  • CMC Crypto 200

    1,360.49
    -31.22 (-2.24%)
     

  • S&P 500

    4,179.40
    +8.98 (+0.22%)
     

  • DOW

    34,168.63
    +132.64 (+0.39%)
     

  • CRUDE OIL

    62.96
    -0.50 (-0.79%)
     

  • GOLD FUTURES

    1,775.00
    +8.20 (+0.46%)
     

  • NIKKEI 225

    29,683.37
    +40.68 (+0.14%)
     

  • HANG SENG

    28,969.71
    +176.57 (+0.61%)
     

  • DAX

    15,417.42
    +162.09 (+1.06%)
     

  • CAC 40

    6,279.27
    +45.13 (+0.72%)
     
Property:

UK second homes surge to record high of 495,000

The number of second homes in Britain rose by 30% prior to the pandemic

Japanese online retailing market led by Rakuten

Alex De Angelis

The Japanese online retailing market has been forecast to reach a value of at least $50 billion by 2015.

Online retailing is central to both the economising and the nesting trends. While Japan has one of the world's highest broadband penetration rates, it has lagged behind developed markets such as United Kingdom and the United States in the willingness of its consumers to shop online.

Many explanations have been advanced for this peculiarity: Japanese consumers love the physical shopping experience; mobile-phone screens are too small; the density of retail establishments means that online shopping has less of a convenience advantage; credit card penetration is low.

With the rise in the Smartphone and mobile internet penetration online retailers have started concentrating on expanding their mobile commerce platform. Consumer buying behaviour is changing as they enjoy the unique shopping experience using Smartphone apps.

Online retailers have begun attracting consumers by providing low prices, a free and quick delivery service, and gift coupons, among others.

According to a recent market report, 'Consumer Attitudes and Online Retail Dynamics in Japan, 2013,' in 2012, electronics represented the largest category group in the Japanese online retail market, with retail sales of JPY1,049.4 billion (29.5%), while food and grocery represented the fastest-growing product category, with a CAGR of 19.46%.

Demographics and changing consumer lifestyles play a pivotal role in the expansion of online retailing in Japan.

An aging population, shrinking household size, and an increase in the number of working women are factors driving online sales in Japan. The current demographics need convenience and enjoyment and many e-retailers are applying the concept of shopping with fun.

Rakuten Inc lead the market with a 26% value share in 2012. Rakuten Inc has established its status in the e-commerce industry and its sales posted a compound annual growth rate (CAGR) of 16% over the past five years.

In 2012, Rakuten Inc launched an e-book, Kobo, to gain access to the digital content market. Additionally, Rakuten Inc invested in social networking site venture, Pinterest, to promote Rakuten sales with a combination of SNS viral marketing.

For more information on the Japanese online retailing market, see the latest research: Japanese Online Retailing Market

Follow us on Twitter @CandMResearch

Latest stories

  • US pulls back on charge Switzerland, Vietnam manipulate currency

    The US Treasury rolled back a Trump-era accusation against Switzerland and Vietnam of manipulating their exchange rates to gain a competitive trade advantage, saying Friday there was "insufficient evidence" for the charge.

  • Today's Mortgage Rates -- April 16, 2021: Fixed Loans Come Down

    Image source: Getty Images Today's fixed mortgage rates are lower than they were yesterday. Here's what they look like on April 16, 2021: Mortgage Type Today's Interest Rate 30-year fixed mortgage 3.

  • Chrissy Teigen Is Back on Twitter: ‘I Choose to Take the Bad With the Good’

    That was a short timeout: Less than a month after Chrissy Teigen said she was quitting Twitter for good — she’s back on the social network. “it feels TERRIBLE to silence yourself and also no longer enjoy belly chuckles randomly throughout the day and also lose like 2000 friends at once lol,” Teigen tweeted Friday. […]

  • Worldwide Interior Design Services Industry to 2025 - Key Drivers, Challenges and Trends - ResearchAndMarkets.com

    The "Global Interior Design Services Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

  • Global Veterinary Pain Management Market to Reach $2 Billion by 2027

    Abstract: - Global Veterinary Pain Management Market to Reach $2 Billion by 2027. - Amid the COVID-19 crisis, the global market for Veterinary Pain Management estimated at US$1.New York, April 16, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Veterinary Pain Management Industry" - https://www.reportlinker.com/p06033239/?utm_source=GNW 3 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at aCAGR of 6.8% over the period 2020-2027. Drugs, one of the segments analyzed in the report, is projected to record 7% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Devices segment is readjusted to a revised 6.3% CAGR for the next 7-year period. - The U.S. Market is Estimated at $350.3 Million, While China is Forecast to Grow at 10.3% CAGR - The Veterinary Pain Management market in the U.S. is estimated at US$350.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$447.4 Million by the year 2027 trailing a CAGR of 10.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR. - Select Competitors (Total 42 Featured) - Assisi Animal HealthBayerBoehringer IngelheimCeva Santé AnimaleChanelleDechra PharmaceuticalsElancoK-Laser USAMerck Animal HealthNorbrook Laboratories Read the full report: https://www.reportlinker.com/p06033239/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Veterinary Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Veterinary Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Veterinary Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Joint Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Joint Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Joint Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for Postoperative Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Postoperative Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Postoperative Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 22: World Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 25: World Current & Future Analysis for Livestock by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 26: World Historic Review for Livestock by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: World 15-Year Perspective for Livestock by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 28: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 29: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 31: World Current & Future Analysis for Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 32: World Historic Review for Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: World 15-Year Perspective for Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 III. MARKET ANALYSIS UNITED STATES Table 34: USA Current & Future Analysis for Veterinary Pain Management by Product - Drugs and Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 35: USA Historic Review for Veterinary Pain Management by Product - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: USA 15-Year Perspective for Veterinary Pain Management by Product - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 Table 37: USA Current & Future Analysis for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: USA Historic Review for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: USA 15-Year Perspective for Veterinary Pain Management by Application - Percentage Breakdown of Value Sales for Other Applications, Joint Pain, Postoperative Pain and Cancer for the Years 2012, 2020 & 2027 Table 40: USA Current & Future Analysis for Veterinary Pain Management by Animal Type - Companion Animals and Livestock - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: USA Historic Review for Veterinary Pain Management by Animal Type - Companion Animals and Livestock Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: USA 15-Year Perspective for Veterinary Pain Management by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock for the Years 2012, 2020 & 2027 Table 43: USA Current & Future Analysis for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: USA Historic Review for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: USA 15-Year Perspective for Veterinary Pain Management by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 CANADA Table 46: Canada Current & Future Analysis for Veterinary Pain Management by Product - Drugs and Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: Canada Historic Review for Veterinary Pain Management by Product - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: Canada 15-Year Perspective for Veterinary Pain Management by Product - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 Table 49: Canada Current & Future Analysis for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Canada Historic Review for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: Canada 15-Year Perspective for Veterinary Pain Management by Application - Percentage Breakdown of Value Sales for Other Applications, Joint Pain, Postoperative Pain and Cancer for the Years 2012, 2020 & 2027 Table 52: Canada Current & Future Analysis for Veterinary Pain Management by Animal Type - Companion Animals and Livestock - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: Canada Historic Review for Veterinary Pain Management by Animal Type - Companion Animals and Livestock Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Canada 15-Year Perspective for Veterinary Pain Management by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock for the Years 2012, 2020 & 2027 Table 55: Canada Current & Future Analysis for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Canada Historic Review for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Canada 15-Year Perspective for Veterinary Pain Management by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 JAPAN Table 58: Japan Current & Future Analysis for Veterinary Pain Management by Product - Drugs and Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: Japan Historic Review for Veterinary Pain Management by Product - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: Japan 15-Year Perspective for Veterinary Pain Management by Product - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 Table 61: Japan Current & Future Analysis for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: Japan Historic Review for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: Japan 15-Year Perspective for Veterinary Pain Management by Application - Percentage Breakdown of Value Sales for Other Applications, Joint Pain, Postoperative Pain and Cancer for the Years 2012, 2020 & 2027 Table 64: Japan Current & Future Analysis for Veterinary Pain Management by Animal Type - Companion Animals and Livestock - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: Japan Historic Review for Veterinary Pain Management by Animal Type - Companion Animals and Livestock Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: Japan 15-Year Perspective for Veterinary Pain Management by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock for the Years 2012, 2020 & 2027 Table 67: Japan Current & Future Analysis for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: Japan Historic Review for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: Japan 15-Year Perspective for Veterinary Pain Management by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 CHINA Table 70: China Current & Future Analysis for Veterinary Pain Management by Product - Drugs and Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 71: China Historic Review for Veterinary Pain Management by Product - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: China 15-Year Perspective for Veterinary Pain Management by Product - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 Table 73: China Current & Future Analysis for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: China Historic Review for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: China 15-Year Perspective for Veterinary Pain Management by Application - Percentage Breakdown of Value Sales for Other Applications, Joint Pain, Postoperative Pain and Cancer for the Years 2012, 2020 & 2027 Table 76: China Current & Future Analysis for Veterinary Pain Management by Animal Type - Companion Animals and Livestock - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: China Historic Review for Veterinary Pain Management by Animal Type - Companion Animals and Livestock Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: China 15-Year Perspective for Veterinary Pain Management by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock for the Years 2012, 2020 & 2027 Table 79: China Current & Future Analysis for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: China Historic Review for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: China 15-Year Perspective for Veterinary Pain Management by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 EUROPE Table 82: Europe Current & Future Analysis for Veterinary Pain Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 83: Europe Historic Review for Veterinary Pain Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: Europe 15-Year Perspective for Veterinary Pain Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 85: Europe Current & Future Analysis for Veterinary Pain Management by Product - Drugs and Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: Europe Historic Review for Veterinary Pain Management by Product - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: Europe 15-Year Perspective for Veterinary Pain Management by Product - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 Table 88: Europe Current & Future Analysis for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: Europe Historic Review for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: Europe 15-Year Perspective for Veterinary Pain Management by Application - Percentage Breakdown of Value Sales for Other Applications, Joint Pain, Postoperative Pain and Cancer for the Years 2012, 2020 & 2027 Table 91: Europe Current & Future Analysis for Veterinary Pain Management by Animal Type - Companion Animals and Livestock - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: Europe Historic Review for Veterinary Pain Management by Animal Type - Companion Animals and Livestock Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: Europe 15-Year Perspective for Veterinary Pain Management by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock for the Years 2012, 2020 & 2027 Table 94: Europe Current & Future Analysis for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 95: Europe Historic Review for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 96: Europe 15-Year Perspective for Veterinary Pain Management by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 FRANCE Table 97: France Current & Future Analysis for Veterinary Pain Management by Product - Drugs and Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 98: France Historic Review for Veterinary Pain Management by Product - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 99: France 15-Year Perspective for Veterinary Pain Management by Product - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 Table 100: France Current & Future Analysis for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 101: France Historic Review for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 102: France 15-Year Perspective for Veterinary Pain Management by Application - Percentage Breakdown of Value Sales for Other Applications, Joint Pain, Postoperative Pain and Cancer for the Years 2012, 2020 & 2027 Table 103: France Current & Future Analysis for Veterinary Pain Management by Animal Type - Companion Animals and Livestock - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 104: France Historic Review for Veterinary Pain Management by Animal Type - Companion Animals and Livestock Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 105: France 15-Year Perspective for Veterinary Pain Management by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock for the Years 2012, 2020 & 2027 Table 106: France Current & Future Analysis for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 107: France Historic Review for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 108: France 15-Year Perspective for Veterinary Pain Management by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 GERMANY Table 109: Germany Current & Future Analysis for Veterinary Pain Management by Product - Drugs and Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 110: Germany Historic Review for Veterinary Pain Management by Product - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 111: Germany 15-Year Perspective for Veterinary Pain Management by Product - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 Table 112: Germany Current & Future Analysis for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 113: Germany Historic Review for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 114: Germany 15-Year Perspective for Veterinary Pain Management by Application - Percentage Breakdown of Value Sales for Other Applications, Joint Pain, Postoperative Pain and Cancer for the Years 2012, 2020 & 2027 Table 115: Germany Current & Future Analysis for Veterinary Pain Management by Animal Type - Companion Animals and Livestock - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 116: Germany Historic Review for Veterinary Pain Management by Animal Type - Companion Animals and Livestock Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 117: Germany 15-Year Perspective for Veterinary Pain Management by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock for the Years 2012, 2020 & 2027 Table 118: Germany Current & Future Analysis for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 119: Germany Historic Review for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 120: Germany 15-Year Perspective for Veterinary Pain Management by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 ITALY Table 121: Italy Current & Future Analysis for Veterinary Pain Management by Product - Drugs and Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 122: Italy Historic Review for Veterinary Pain Management by Product - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 123: Italy 15-Year Perspective for Veterinary Pain Management by Product - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 Table 124: Italy Current & Future Analysis for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 125: Italy Historic Review for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 126: Italy 15-Year Perspective for Veterinary Pain Management by Application - Percentage Breakdown of Value Sales for Other Applications, Joint Pain, Postoperative Pain and Cancer for the Years 2012, 2020 & 2027 Table 127: Italy Current & Future Analysis for Veterinary Pain Management by Animal Type - Companion Animals and Livestock - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 128: Italy Historic Review for Veterinary Pain Management by Animal Type - Companion Animals and Livestock Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 129: Italy 15-Year Perspective for Veterinary Pain Management by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock for the Years 2012, 2020 & 2027 Table 130: Italy Current & Future Analysis for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 131: Italy Historic Review for Veterinary Pain Management by Distribution Channel - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 132: Italy 15-Year Perspective for Veterinary Pain Management by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 133: UK Current & Future Analysis for Veterinary Pain Management by Product - Drugs and Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 134: UK Historic Review for Veterinary Pain Management by Product - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 135: UK 15-Year Perspective for Veterinary Pain Management by Product - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2012, 2020 & 2027 Table 136: UK Current & Future Analysis for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 137: UK Historic Review for Veterinary Pain Management by Application - Other Applications, Joint Pain, Postoperative Pain and Cancer Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 138: UK 15-Year Perspective for Veterinary Pain Management by Application - Percentage Breakdown of Value Sales for Other Applications, Joint Pain, Postoperative Pain and Cancer for the Years 2012, 2020 & 2027 Table 139: UK Current & Future Analysis for Veterinary Pain Management by Animal Type - Companion Animals and Livestock - Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p06033239/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Digital divide hampers Stockholm vaccinations as elderly struggle to book

    Thousands of vaccination slots in Stockholm earmarked for Sweden's oldest and frailest people are being passed on to younger patients, with critics accusing the region of failing to adapt the process for those not used to digital technology. In the capital region, home to about 2.3 million of the country's 10.3 million inhabitants, vaccinations are falling behind. Vaccinations are primarily handled by the health clinics at which people are registered, but to speed up, the region has opened 10 vaccination centres.

  • How Real Estate Investors Are Using Clubhouse

    If you haven't heard by now, there's another social media app in town: Clubhouse. The new social media platform is invite-only and allows users to connect via audio. Clubhouse has become a place where deals get done, so real estate investors should take note.

  • Oregon Oncology Specialists Integrate AI-screening Solution VIPER™ Into Network to Expand Patient Access to Clinical Trials

    Deep Lens and Oregon Oncology Specialists today announced a strategic collaboration that will integrate Deep Lens’ artificial-intelligence (AI)-based clinical trial screening platform, VIPER™, into their community oncology practice network. VIPER uses proprietary cloud-based technology to facilitate, triage and accelerate the clinical trial recruitment process. The VIPER technology will expand patient access to trials and ensure that eligible patients are identified sooner in the clinical trial enrollment process.

  • Man City's De Bruyne approaching peak form in home stretch - Guardiola

    Premier League leaders City are chasing a quadruple this season and face a stern test on Saturday when they take on Chelsea in the FA Cup semi-finals. "He's arriving in a good feeling... He's arriving for the next six weeks in the best condition physically and mentally," Guardiola told reporters. Striker Sergio Aguero will not be involved and Guardiola said the squad were tired after their midweek Champions League win in Dortmund but were in high spirits after City advanced to the semi-finals for the first time under the Spaniard.

  • Government spends £66,000 on lobbyists register run by part-time boss

    Government spends £66,000 on lobbyists register run by part-time bossOffice set up by David Cameron after series of scandals is limited by narrow powers and meagre resources The office was founded with a pledge to increase transparency around lobbying activities. Photograph: Vuk Valcic/Sopa Images/Rex/Shutterstock

  • Everton vs Tottenham predicted line-ups: Team news ahead of Premier League fixture tonight

    Full details ahead of tonight’s game

  • Everton vs Tottenham prediction: How will Premier League fixture play out tonight?

    Everything you need to know about tonight’s clash

  • 10 best running headphones: Wireless earbuds that won’t fall out during a workout

    Whether you're in the gym or exercising outside, soundtrack your session with these smart earbuds

  • London’s best pub gardens to watch the football

    Catch the action al fresco, says Barney Davis

  • Global Veterinary Rapid Testing Market to Reach $949.7 Million by 2027

    Abstract: - Global Veterinary Rapid Testing Market to Reach $949. 7 Million by 2027. - Amid the COVID-19 crisis, the global market for Veterinary Rapid Testing estimated at US$600.New York, April 16, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Veterinary Rapid Testing Industry" - https://www.reportlinker.com/p06033240/?utm_source=GNW 3 Million in the year 2020, is projected to reach a revised size of US$949.7 Million by 2027, growing at aCAGR of 6.8% over the period 2020-2027. Hospitals & Clinics, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$645.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Pharmacy segment is readjusted to a revised 6.1% CAGR for the next 7-year period. - The U.S. Market is Estimated at $162.4 Million, While China is Forecast to Grow at 10.4% CAGR - The Veterinary Rapid Testing market in the U.S. is estimated at US$162.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$207.8 Million by the year 2027 trailing a CAGR of 10.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR. - Select Competitors (Total 42 Featured) - BioNote, Inc.Biopanda Reagents, Ltd.Fassisi GmbHHeska CorporationIDEXX Laboratories, Inc.Megacor Diagnostik GmbHSwissavanss AGVirbacWoodley Equipment Company, Ltd.Zoetis, Inc. Read the full report: https://www.reportlinker.com/p06033240/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Veterinary Rapid Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Veterinary Rapid Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Veterinary Rapid Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Livestock Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Livestock Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Livestock Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for Viral Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Viral Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Viral Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Bacterial Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Bacterial Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Bacterial Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 22: World Current & Future Analysis for Parasitic Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Parasitic Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Parasitic Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 25: World Current & Future Analysis for Allergies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 26: World Historic Review for Allergies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: World 15-Year Perspective for Allergies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 28: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 29: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 III. MARKET ANALYSIS UNITED STATES Table 31: USA Current & Future Analysis for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 32: USA Historic Review for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: USA 15-Year Perspective for Veterinary Rapid Testing by Product Segment - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 Table 34: USA Current & Future Analysis for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 35: USA Historic Review for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: USA 15-Year Perspective for Veterinary Rapid Testing by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2012, 2020 & 2027 Table 37: USA Current & Future Analysis for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: USA Historic Review for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: USA 15-Year Perspective for Veterinary Rapid Testing by Application - Percentage Breakdown of Value Sales for Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications for the Years 2012, 2020 & 2027 CANADA Table 40: Canada Current & Future Analysis for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: Canada Historic Review for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: Canada 15-Year Perspective for Veterinary Rapid Testing by Product Segment - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 Table 43: Canada Current & Future Analysis for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: Canada Historic Review for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: Canada 15-Year Perspective for Veterinary Rapid Testing by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2012, 2020 & 2027 Table 46: Canada Current & Future Analysis for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: Canada Historic Review for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: Canada 15-Year Perspective for Veterinary Rapid Testing by Application - Percentage Breakdown of Value Sales for Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications for the Years 2012, 2020 & 2027 JAPAN Table 49: Japan Current & Future Analysis for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Japan Historic Review for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: Japan 15-Year Perspective for Veterinary Rapid Testing by Product Segment - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 Table 52: Japan Current & Future Analysis for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: Japan Historic Review for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Japan 15-Year Perspective for Veterinary Rapid Testing by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2012, 2020 & 2027 Table 55: Japan Current & Future Analysis for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Japan Historic Review for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Japan 15-Year Perspective for Veterinary Rapid Testing by Application - Percentage Breakdown of Value Sales for Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications for the Years 2012, 2020 & 2027 CHINA Table 58: China Current & Future Analysis for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: China Historic Review for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: China 15-Year Perspective for Veterinary Rapid Testing by Product Segment - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 Table 61: China Current & Future Analysis for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: China Historic Review for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: China 15-Year Perspective for Veterinary Rapid Testing by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2012, 2020 & 2027 Table 64: China Current & Future Analysis for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: China Historic Review for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: China 15-Year Perspective for Veterinary Rapid Testing by Application - Percentage Breakdown of Value Sales for Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications for the Years 2012, 2020 & 2027 EUROPE Table 67: Europe Current & Future Analysis for Veterinary Rapid Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 68: Europe Historic Review for Veterinary Rapid Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: Europe 15-Year Perspective for Veterinary Rapid Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 70: Europe Current & Future Analysis for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 71: Europe Historic Review for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: Europe 15-Year Perspective for Veterinary Rapid Testing by Product Segment - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 Table 73: Europe Current & Future Analysis for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: Europe Historic Review for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: Europe 15-Year Perspective for Veterinary Rapid Testing by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2012, 2020 & 2027 Table 76: Europe Current & Future Analysis for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: Europe Historic Review for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: Europe 15-Year Perspective for Veterinary Rapid Testing by Application - Percentage Breakdown of Value Sales for Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications for the Years 2012, 2020 & 2027 FRANCE Table 79: France Current & Future Analysis for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: France Historic Review for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: France 15-Year Perspective for Veterinary Rapid Testing by Product Segment - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 Table 82: France Current & Future Analysis for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: France Historic Review for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: France 15-Year Perspective for Veterinary Rapid Testing by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2012, 2020 & 2027 Table 85: France Current & Future Analysis for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: France Historic Review for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: France 15-Year Perspective for Veterinary Rapid Testing by Application - Percentage Breakdown of Value Sales for Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications for the Years 2012, 2020 & 2027 GERMANY Table 88: Germany Current & Future Analysis for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: Germany Historic Review for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: Germany 15-Year Perspective for Veterinary Rapid Testing by Product Segment - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 Table 91: Germany Current & Future Analysis for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: Germany Historic Review for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: Germany 15-Year Perspective for Veterinary Rapid Testing by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2012, 2020 & 2027 Table 94: Germany Current & Future Analysis for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 95: Germany Historic Review for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 96: Germany 15-Year Perspective for Veterinary Rapid Testing by Application - Percentage Breakdown of Value Sales for Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications for the Years 2012, 2020 & 2027 ITALY Table 97: Italy Current & Future Analysis for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 98: Italy Historic Review for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 99: Italy 15-Year Perspective for Veterinary Rapid Testing by Product Segment - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 Table 100: Italy Current & Future Analysis for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 101: Italy Historic Review for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 102: Italy 15-Year Perspective for Veterinary Rapid Testing by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2012, 2020 & 2027 Table 103: Italy Current & Future Analysis for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 104: Italy Historic Review for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 105: Italy 15-Year Perspective for Veterinary Rapid Testing by Application - Percentage Breakdown of Value Sales for Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 106: UK Current & Future Analysis for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 107: UK Historic Review for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 108: UK 15-Year Perspective for Veterinary Rapid Testing by Product Segment - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 Table 109: UK Current & Future Analysis for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 110: UK Historic Review for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 111: UK 15-Year Perspective for Veterinary Rapid Testing by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2012, 2020 & 2027 Table 112: UK Current & Future Analysis for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 113: UK Historic Review for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 114: UK 15-Year Perspective for Veterinary Rapid Testing by Application - Percentage Breakdown of Value Sales for Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications for the Years 2012, 2020 & 2027 SPAIN Table 115: Spain Current & Future Analysis for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 116: Spain Historic Review for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 117: Spain 15-Year Perspective for Veterinary Rapid Testing by Product Segment - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 Table 118: Spain Current & Future Analysis for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 119: Spain Historic Review for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 120: Spain 15-Year Perspective for Veterinary Rapid Testing by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2012, 2020 & 2027 Table 121: Spain Current & Future Analysis for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 122: Spain Historic Review for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 123: Spain 15-Year Perspective for Veterinary Rapid Testing by Application - Percentage Breakdown of Value Sales for Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications for the Years 2012, 2020 & 2027 RUSSIA Table 124: Russia Current & Future Analysis for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 125: Russia Historic Review for Veterinary Rapid Testing by Product Segment - Hospitals & Clinics and Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 126: Russia 15-Year Perspective for Veterinary Rapid Testing by Product Segment - Percentage Breakdown of Value Sales for Hospitals & Clinics and Pharmacy for the Years 2012, 2020 & 2027 Table 127: Russia Current & Future Analysis for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 128: Russia Historic Review for Veterinary Rapid Testing by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 129: Russia 15-Year Perspective for Veterinary Rapid Testing by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2012, 2020 & 2027 Table 130: Russia Current & Future Analysis for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 131: Russia Historic Review for Veterinary Rapid Testing by Application - Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 132: Russia 15-Year Perspective for Veterinary Rapid Testing by Application - Percentage Breakdown of Value Sales for Viral Diseases, Bacterial Diseases, Parasitic Diseases, Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p06033240/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • What investors can learn from strong bank earnings

    Steve Sosnick, Interactive Brokers chief strategist, joins Yahoo Finance to discuss market volatility, bank earnings, and cryptocurrency.

  • Quiz! How well do you remember 'Game of Thrones' season 1?

    As fans marks10 years since the series premiered, how much do you remember?

  • Fantasy Premier League tips gameweek 32: Son Heung-min, Kelechi Iheanacho, Mason Greenwood and more

    How many of our picks are in your squad?

  • The 2 Big Reasons We've Stopped Making Extra Mortgage Payments

    When you pay off a debt early, your return on investment is the interest you save. Since mortgage interest rates are generally well below what you earn by investing in the stock market, you're usually better off investing instead of paying off home loan debt ahead of schedule. Despite this basic mathematical reality, we still made extra mortgage payments when our rate was around 4%, because we liked the idea of not having this loan any more.

  • The 6 best MagSafe cases for the iPhone 12 series — Nomad, Otterbox, Casetify and more

    More and more third-party companies are creating MagSafe cases for the iPhone 12 lineup. Here are six of the best.